InCrowd and Survey Healthcare Global are now part of Konovo

Global Pulmonary Market Insights and Therapeutic Area Data


Comprehensive Access to Verified HCPs and In-Depth Data Across Asthma, COPD, IPF, and Other Key Pulmonary Conditions


Konovo’s Pulmonary Therapeutic Breakdown offers a detailed view into global market research capabilities across critical respiratory conditions, including asthma, COPD, cystic fibrosis, idiopathic pulmonary fibrosis (IPF), pneumonia, sleep disorders, respiratory syncytial virus (RSV), and pulmonary arterial hypertension (PAH). With more than 315 projects completed and 18,925 respondent completes over the past three years, we leverage a panel of 2 million+ verified healthcare professionals across 150 therapeutic areas. Our unmatched reach—spanning the Americas, Canada, Europe, and Asia—ensures representative, high-quality samples supported by rigorous quality controls. By combining proprietary technologies with expert project management, Konovo delivers accurate, actionable pulmonary market insights to help pharmaceutical, biotech, and medical device companies make informed, data-driven decisions.

Pulmonary-Therapeutic-Breakdown-Global

You may also be interested in:

Global Cardiovascular Research & Data Collection Expertise

Keep Reading

Global Dermatology Market Insights and Condition-Specific Data

Keep Reading

Global Rheumatology Market Insights and Condition-Specific Data

Keep Reading